Literature DB >> 14530154

Proliferation and micromilieu during fractionated irradiation of human FaDu squamous cell carcinoma in nude mice.

C Petersen1, W Eicheler, A Frömmel, M Krause, S Balschukat, D Zips, M Baumann.   

Abstract

PURPOSE: Previous functional radiobiological experiments demonstrated a significant acceleration of repopulation after 3 weeks and reoxygenation after 12 days of radiotherapy of FaDu tumours. Owing to the temporal coincidence between repopulation and reoxygenation, it was hypothesized that the improved oxygenation status during fractionated irradiation might be the preceding stimulus for increased proliferation. The study investigated whether these changes in repopulation and re-oxygenation are reflected by histological parameters of proliferation and the tumour micromilieu.
MATERIALS AND METHODS: Human FaDu squamous cell carcinomas in nude mice were irradiated with three to 18 fractions of 3 Gy daily or every second day under normal blood flow and clamp hypoxia. At different time points, tumours were excised and stained for Ki67, BrdUrd, epidermal growth factor receptor (EGFR) and markers of the micromilieu (HOECHST 33342, pimonidazole, ER-MP12).
RESULTS: On average, Ki67 and BrdUrd labelling indices decreased initially and increased again at later times during the course of fractionated radiotherapy. A similar kinetic pattern was found for the staining intensity of the EGFR. The vascular density in the viable tumour area remained constant during the whole course of irradiation, while the perfused fraction of vessels decreased within the first week of irradiation and returned to baseline values after 2 weeks. There was a corresponding increase in perfusion and a decrease in cellular hypoxia.
CONCLUSIONS: The histological results were in surprisingly good agreement with the kinetics of clonogen repopulation and re-oxygenation determined previously using functional assays. The results support that the kinetics of repopulation of FaDu squamous cell carcinoma in response to fractionated irradiation are determined not only by intracellular processes, but also by a complex interaction of proliferation parameters with a changing microenvironment.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14530154     DOI: 10.1080/09553000310001609224

Source DB:  PubMed          Journal:  Int J Radiat Biol        ISSN: 0955-3002            Impact factor:   2.694


  10 in total

Review 1.  Radiation oncology in the era of precision medicine.

Authors:  Michael Baumann; Mechthild Krause; Jens Overgaard; Jürgen Debus; Søren M Bentzen; Juliane Daartz; Christian Richter; Daniel Zips; Thomas Bortfeld
Journal:  Nat Rev Cancer       Date:  2016-03-18       Impact factor: 60.716

2.  Topotecan can compensate for protracted radiation treatment time effects in high grade glioma xenografts.

Authors:  Sophie Pinel; Pascal Chastagner; Jean-Louis Merlin; Christian Marchal; Alphonse Taghian; Muriel Barberi-Heyob
Journal:  J Neurooncol       Date:  2006-01       Impact factor: 4.130

3.  The reoxygenation of hypoxia and the reduction of glucose metabolism in head and neck cancer by fractionated radiotherapy with intensity-modulated radiation therapy.

Authors:  Shozo Okamoto; Tohru Shiga; Koichi Yasuda; Shiro Watanabe; Kenji Hirata; Ken-Ichi Nishijima; Keiichi Magota; Katsuhiko Kasai; Rikiya Onimaru; Kazuhiko Tuchiya; Yuji Kuge; Hiroki Shirato; Nagara Tamaki
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-06-01       Impact factor: 9.236

4.  Modelling the interplay between hypoxia and proliferation in radiotherapy tumour response.

Authors:  J Jeong; K I Shoghi; J O Deasy
Journal:  Phys Med Biol       Date:  2013-06-21       Impact factor: 3.609

5.  Effect of celecoxib on inhibiting tumor repopulation during radiotherapy in human FaDu squamous cell carcinoma.

Authors:  Jia Yang; Jin-Bo Yue; Jing Liu; Xin-Dong Sun; Xu-Dong Hu; Ju-Jie Sun; Yu-Hui Li; Jin-Ming Yu
Journal:  Contemp Oncol (Pozn)       Date:  2014-08-03

6.  Downregulation of EGFR in hypoxic, diffusion-limited areas of squamous cell carcinomas of the head and neck.

Authors:  Arnulf Mayer; Sebastian Zahnreich; Jürgen Brieger; Peter Vaupel; Heinz Schmidberger
Journal:  Br J Cancer       Date:  2016-11-01       Impact factor: 7.640

7.  EGFR and K-ras gene mutation status in squamous cell anal carcinoma: a role for concurrent radiation and EGFR inhibitors?

Authors:  A Paliga; R Onerheim; A Gologan; G Chong; A Spatz; T Niazi; A Garant; D Macheto; T Alcindor; T Vuong
Journal:  Br J Cancer       Date:  2012-10-23       Impact factor: 7.640

8.  Repopulation of tumor cells during fractionated radiotherapy and detection methods (Review).

Authors:  Jia Yang; Jin-Bo Yue; Jing Liu; Jin-Ming Yu
Journal:  Oncol Lett       Date:  2014-03-21       Impact factor: 2.967

9.  Dual tracer evaluation of dynamic changes in intratumoral hypoxic and proliferative states after radiotherapy of human head and neck cancer xenografts using radiolabeled FMISO and FLT.

Authors:  Chowdhury Nusrat Fatema; Songji Zhao; Yan Zhao; Wenwen Yu; Ken-ichi Nishijima; Koichi Yasuda; Yoshimasa Kitagawa; Nagara Tamaki; Yuji Kuge
Journal:  BMC Cancer       Date:  2014-09-22       Impact factor: 4.430

10.  Selectivity Conversion of Protease Inhibitory Antibodies.

Authors:  Tyler Lopez; Aaron Ramirez; Chris Benitez; Zahid Mustafa; Henry Pham; Ramon Sanchez; Xin Ge
Journal:  Antib Ther       Date:  2018-10-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.